Long-term Rosiglitazone Use Linked To Raised Heart Attack And Heart Failure Risk

Receiving rosiglitazone long-term raises the risk for heart failure and heart attack, according to a report in the Journal of the American Medical Association (JAMA). Rosiglitazone is a glycemic control medication given to patients with Diabetes Type 2 and people with glucose intolerance. Sonal Singh, M.D., Wake Forest University School of Medicine, Winston-Salem, N.C. [click link for full article]

More: continued here

Filed under: Cardiovascular on September 12th, 2007